Lecanemab Access, Diabetes and Brain Health, and Global Life Expectancy Trends

In this episode, Dr. Chi-Ming Chow begins with an introduction to the latest medical updates. He discusses the use of lecanemab in Alzheimer's treatment, highlighting access disparities. The conversation moves to the impact of Type 2 diabetes mellitus on brain health. Dr. Chow explores the ongoing debate over universal health care in Maine and shares insights into a gene editing breakthrough for rare genetic disorders. A WHO report on the global decline in life expectancy is examined, followed by a discussion on Amy Larocca's book about the wellness industry. The episode concludes with closing remarks and a sign-off.